Clinical trial
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic…
NCT00474955 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00474955 |
|---|---|
| Title | A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure. |
| Official title | Multicenter Open-label Observation Program in Patients With Chronic Hepatitis C and With Chronic Renal Failure (CRF) Receiving Peginterferon Alpha-2a (40 kDa) Pegasys |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis C, Chronic |
| Intervention type | Drug |
| Interventions | peginterferon alfa-2a [Pegasys] |
| Enrollment | 27 |
| Start date | Jul 1, 2007 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | May 17, 2007 |
| Last update posted | Jul 25, 2016 |
| Countries | Russia |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: